CN110261353A - A kind of zero background fluorescence detection method and its application of hydrazine - Google Patents
A kind of zero background fluorescence detection method and its application of hydrazine Download PDFInfo
- Publication number
- CN110261353A CN110261353A CN201910406958.3A CN201910406958A CN110261353A CN 110261353 A CN110261353 A CN 110261353A CN 201910406958 A CN201910406958 A CN 201910406958A CN 110261353 A CN110261353 A CN 110261353A
- Authority
- CN
- China
- Prior art keywords
- hydrazine
- detection method
- zero
- background fluorescence
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 title claims abstract description 231
- 238000000034 method Methods 0.000 title claims abstract description 33
- 238000001917 fluorescence detection Methods 0.000 title claims abstract description 20
- 238000001514 detection method Methods 0.000 claims abstract description 54
- HNJXPTMEWIVQQM-UHFFFAOYSA-M triethyl(hexadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](CC)(CC)CC HNJXPTMEWIVQQM-UHFFFAOYSA-M 0.000 claims abstract description 45
- 238000006482 condensation reaction Methods 0.000 claims abstract description 16
- 238000011065 in-situ storage Methods 0.000 claims abstract description 13
- 238000003384 imaging method Methods 0.000 claims abstract description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
- 239000001257 hydrogen Substances 0.000 claims abstract description 6
- XFVZSRRZZNLWBW-UHFFFAOYSA-N 4-(Diethylamino)salicylaldehyde Chemical compound CCN(CC)C1=CC=C(C=O)C(O)=C1 XFVZSRRZZNLWBW-UHFFFAOYSA-N 0.000 claims description 51
- 239000000126 substance Substances 0.000 claims description 19
- 239000000693 micelle Substances 0.000 claims description 15
- 239000012491 analyte Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 11
- 239000000872 buffer Substances 0.000 claims description 5
- 239000012429 reaction media Substances 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 abstract description 26
- 230000035945 sensitivity Effects 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 238000012360 testing method Methods 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 4
- 210000002966 serum Anatomy 0.000 abstract description 4
- 229960004194 lidocaine Drugs 0.000 abstract 2
- 238000002474 experimental method Methods 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000010859 live-cell imaging Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- -1 K + Substances 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000012984 biological imaging Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
技术领域technical field
本发明属于肼检测技术领域,涉及一种用于检测肼的方法策略。更具体地,涉及一种肼的零背景荧光检测方法及其应用。The invention belongs to the technical field of hydrazine detection, and relates to a method strategy for detecting hydrazine. More specifically, it relates to a zero-background fluorescence detection method for hydrazine and its application.
背景技术Background technique
众所周知,肼是一种广泛使用的火箭推进剂,由于其固有的强碱性和还原性,在工业领域中应用广泛,主要用于制造化学催化剂,医药中间体和农用化学品。然而,世界卫生组织将肼定义为生产和运输过程中的具有剧毒性和致癌性的环境污染物,并且阈值限值定为10ppb。此外,肼的水溶性极佳,易通过口腔和皮肤接触吸收,对肾脏、肺脏、肝脏甚至中枢神经系统等人体器官造成严重的损害。因此,对于肼的检测,监测其痕量浓度是十分重要的,从而满足在水溶液中高灵敏度和具有良好传感性能的需求。As we all know, hydrazine is a widely used rocket propellant. Due to its inherent strong alkalinity and reducing properties, it is widely used in industrial fields, mainly for the manufacture of chemical catalysts, pharmaceutical intermediates and agricultural chemicals. However, the World Health Organization defines hydrazine as a highly toxic and carcinogenic environmental pollutant during production and transportation, and the threshold limit is set at 10ppb. In addition, hydrazine has excellent water solubility and is easily absorbed through oral and skin contact, causing serious damage to human organs such as kidneys, lungs, liver and even the central nervous system. Therefore, for the detection of hydrazine, it is very important to monitor its trace concentration to meet the demand of high sensitivity and good sensing performance in aqueous solution.
目前,肼的检测的常用分析方法主要有电化学分析、HPLC/GS-MS方法和毛细管电泳,但这些方法通常需要在高成本的实验仪器上进行,样品制备繁琐,并且与荧光探针相比,不适用于生物系统中的分析。At present, the commonly used analytical methods for the detection of hydrazine mainly include electrochemical analysis, HPLC/GS-MS method and capillary electrophoresis, but these methods usually need to be carried out on high-cost experimental instruments, the sample preparation is cumbersome, and compared with fluorescent probes , not suitable for analysis in biological systems.
荧光探针作为一种在对目标物的传感中具有特殊光学特性的化合物,其能够满足日益增长的解决环境污染和人类健康问题的需求,并且荧光探针在灵敏度和选择性方面取得了很大进步。迄今已开发出一系列适用于实际样品、活细胞甚至生物体的荧光探针,这些探针简单易行,可用于标记或生物成像,使它们在疾病的早期诊断和环境污染检测方面具有巨大潜力。Fluorescent probes, as a compound with special optical properties in the sensing of targets, can meet the growing needs of solving environmental pollution and human health problems, and fluorescent probes have made great achievements in sensitivity and selectivity. Great progress. So far, a series of fluorescent probes suitable for actual samples, living cells and even organisms have been developed. These probes are simple and easy to use for labeling or biological imaging, making them have great potential in early diagnosis of diseases and detection of environmental pollution. .
此外,为了提高荧光探针的分析灵敏度和信噪比,虽然目前文献报道中,已经有多种方法设计和构建分子结构来提高响应信号或减少背景干扰。例如,通过扭曲的分子内电荷转移(TICT)、荧光共振能量转移(FRET)和光致电子转移(PET)等光物理过程设计探针结构。但是使用探针和分析物原位生成发色团的分析方法可以完全避免背景荧光的干扰,并且该类探针通常具有巧妙的分子结构,其本身是不发光的,与分析物结合可自行产生发光体实现对分析物的检测,以及简单的分子结构可有效地避免繁琐的合成及纯化过程,其是目前比较具有应用价值的水中肼检测方法,通过探针和目标分析物之间的特定反应生成发色团的分析方法,为实现目标物的高灵敏度零背景检测提供了一种新思路。In addition, in order to improve the analytical sensitivity and signal-to-noise ratio of fluorescent probes, although currently reported in the literature, there have been a variety of methods to design and construct molecular structures to improve the response signal or reduce background interference. For example, probe structures are designed through photophysical processes such as twisted intramolecular charge transfer (TICT), fluorescence resonance energy transfer (FRET), and photoinduced electron transfer (PET). However, the analysis method that uses probes and analytes to generate chromophores in situ can completely avoid the interference of background fluorescence, and such probes usually have ingenious molecular structures, which themselves are not luminescent, and can be self-generated when combined with analytes The luminophore realizes the detection of the analyte, and the simple molecular structure can effectively avoid the tedious synthesis and purification process. It is currently a relatively valuable method for the detection of hydrazine in water, through the specific reaction between the probe and the target analyte The analytical method of generating chromophores provides a new idea for the high-sensitivity and zero-background detection of target substances.
发明内容Contents of the invention
有鉴于此,本发明的目的是针对现有技术中存在的问题,提供一种CTAB胶束促进4-二乙氨基水杨醛与肼的缩合反应,原位生成的发色团作为肼检测指示剂的新型传感策略。In view of this, the purpose of the present invention is to address the problems in the prior art, provide a CTAB micelles to promote the condensation reaction of 4-diethylamino salicylaldehyde and hydrazine, the chromophore generated in situ as a hydrazine detection indicator Novel sensing strategies for agents.
为了实现上述目的,本发明的技术方案如下:In order to achieve the above object, the technical scheme of the present invention is as follows:
一种肼的零背景荧光检测方法,通过十六烷基三乙基溴化铵(CTAB)胶束促进4-二乙氨基水杨醛与分析物肼之间的缩合反应,原位生成的具有分子内氢键的新生色团作为肼检测的指示剂。A zero-background fluorescence detection method for hydrazine, the condensation reaction between 4-diethylaminosalicylaldehyde and the analyte hydrazine is promoted by cetyltriethylammonium bromide (CTAB) micelles, and the in situ generated A new chromophore for intramolecular hydrogen bonding serves as an indicator for hydrazine detection.
本发明通过4-二乙氨基水杨醛(DEASA)在CTAB胶束中与肼的缩合反应,原位生成的新生色团作为肼检测的荧光指示剂,实现了水相中肼的零背景检测,避免了繁琐的有机合成及有机溶剂的使用。In the present invention, through the condensation reaction of 4-diethylamino salicylaldehyde (DEASA) with hydrazine in CTAB micelles, the new chromophore generated in situ is used as a fluorescent indicator for hydrazine detection, and the zero-background detection of hydrazine in the aqueous phase is realized. , avoiding the cumbersome organic synthesis and the use of organic solvents.
上述公开的具体检测方法,包括如下步骤:The specific detection method disclosed above includes the following steps:
步骤一:在比色管中加入PBS缓冲液作为溶剂;Step 1: Add PBS buffer as a solvent in the colorimetric tube;
步骤二:向步骤一的溶剂中加入探针DEASA和特定浓度的CTAB。Step 2: Add probe DEASA and specific concentration of CTAB to the solvent in step 1.
步骤三:向步骤二的溶液中加入分析物肼,DEASA与肼发生缩合反应,生成发光物质HDBM。Step 3: adding the analyte hydrazine to the solution in step 2, DEASA and hydrazine undergo a condensation reaction to generate the luminescent substance HDBM.
需要说明的是,上述缩合反应的反应温度为室温,反应迅速。It should be noted that the reaction temperature of the above condensation reaction is room temperature, and the reaction is rapid.
优选的,所述新生色团的合成方法具体包括如下步骤:Preferably, the synthesis method of the new chromophore specifically includes the following steps:
(1)以PBS缓冲液为反应介质,加入4-二乙氨基水杨醛和十六烷基三乙基溴化铵(CTAB);(1) Using PBS buffer as the reaction medium, add 4-diethylamino salicylaldehyde and cetyltriethylammonium bromide (CTAB);
(2)在步骤(1)得到的溶液中加入分析物肼,DEASA与肼发生缩合反应,最终生成本发明公开的新生色团—发光物质HDBM。(2) The analyte hydrazine is added to the solution obtained in step (1), and the DEASA and hydrazine undergo a condensation reaction to finally generate the new chromophore disclosed in the present invention—a luminescent substance HDBM.
需要说明的是,参见说明书附图1,本发明通过核磁共振氢谱对所生成的发光物质HDBM进行结构表征,以表明通过上述合成方法成功生成发光物质HDBM。It should be noted that, referring to the accompanying drawing 1 of the specification, the present invention conducts structural characterization of the generated luminescent substance HDBM by hydrogen nuclear magnetic resonance spectroscopy, to show that the luminescent substance HDBM is successfully generated by the above synthesis method.
特别的,本发明公开的制备发光物质HDBM的具体方案如下:In particular, the specific scheme for preparing the luminescent material HDBM disclosed in the present invention is as follows:
通过等摩尔连续变化法(Job法)测得肼和DEASA的结合比为1:2,通过在不同浓度的CTAB存在下检测反应溶液的光谱,优化的CTAB浓度为1×10-3mol·L-1,因而在5mL比色管中加入2mL的PBS缓冲液作为溶剂,向其中加入20μL DEASA的DMSO溶液(5×10-3mol·L-1)后,然后加入2μL CTAB的水溶液(1mol·L-1),再加入0.5当量的肼后,即得到发光物质HDBM。The binding ratio of hydrazine and DEASA was determined to be 1:2 by the equimolar continuous change method (Job method). By detecting the spectrum of the reaction solution in the presence of different concentrations of CTAB, the optimized CTAB concentration was 1×10 -3 mol·L -1 , so add 2mL of PBS buffer as a solvent in a 5mL colorimetric tube, add 20μL DEASA DMSO solution (5× 10-3 mol L -1 ), and then add 2μL CTAB aqueous solution (1mol· L -1 ), after adding 0.5 equivalent of hydrazine, the luminescent substance HDBM is obtained.
其中,本发明中生成的发光物质HDBM的结构为:Wherein, the structure of the luminescent substance HDBM generated in the present invention is:
优选的,所述分析物肼和4-二乙氨基水杨醛的摩尔比为1:2。Preferably, the molar ratio of the analyte hydrazine to 4-diethylamino salicylaldehyde is 1:2.
值得说明的是,在本发明中分析物肼和4-二乙氨基水杨醛的摩尔比为1:2时具有最好的发光效果,故本申请公开的荧光检测方法中均选用二者的摩尔比为1:2。It is worth noting that in the present invention, the molar ratio of the analyte hydrazine and 4-diethylaminosalicylaldehyde is 1:2, which has the best luminescent effect, so the fluorescence detection method disclosed in this application is selected from both. The molar ratio is 1:2.
优选的,所述十六烷基三乙基溴化铵(CTAB)的浓度控制在0.1~5×10-3mol·L-1之间。Preferably, the concentration of cetyltriethylammonium bromide (CTAB) is controlled between 0.1˜5×10 −3 mol·L −1 .
其中,本发明将十六烷基三乙基溴化铵(CTAB)的浓度控制在0.1~5×10-3mol·L-1范围内可以促进发光物质HDBM的生成,且本发明优选的浓度为1×10-3mol·L-1。并且申请人对CTAB的浓度考察范围为0.1~5×10-3mol·L-1,如附图3可知,当CTAB的浓度为1×10- 3mol·L-1时,发光物质HDBM的荧光强度最高,所以后续实验优选CTAB的浓度为1×10-3mol·L-1。Among them, in the present invention, controlling the concentration of cetyltriethylammonium bromide (CTAB) within the range of 0.1 to 5×10 -3 mol·L -1 can promote the formation of the luminescent substance HDBM, and the preferred concentration of the present invention is is 1×10 -3 mol·L -1 . And the applicant's investigation range of the concentration of CTAB is 0.1~5×10 -3 mol·L -1 , as shown in Figure 3 , when the concentration of CTAB is 1×10 -3 mol·L -1 , the luminescent substance HDBM The fluorescence intensity is the highest, so the concentration of CTAB is preferably 1×10 -3 mol·L -1 for subsequent experiments.
本发明还有一个目的,就是提供一种肼的零背景荧光检测方法在溶剂体系中肼的选择性识别和定量检测中的应用。Another object of the present invention is to provide an application of a zero-background fluorescence detection method for hydrazine in the selective identification and quantitative detection of hydrazine in a solvent system.
优选的,所述溶剂体系中的十六烷基三乙基溴化铵(CTAB)的浓度为1×10-3mol·L-1。Preferably, the concentration of cetyltriethylammonium bromide (CTAB) in the solvent system is 1×10 -3 mol·L -1 .
在一些应用场景中,还包括所述检测方法在以肼为标志物的检测及成像中的应用。In some application scenarios, it also includes the application of the detection method in the detection and imaging of hydrazine as a marker.
值得说明的是,本发明公开了4-二乙基氨基水杨醛(DEASA)与肼之间的缩合反应生成的发色团的肼传感策略。其中,十六烷基三甲基溴化铵(CTAB)胶束提供了稳定的疏水空腔,有利于DEASA和肼在胶束界面发生缩合反应。同时,产生的发光物质在CTAB胶束的保护下具有更好的发光性能,从而可以提高检测的灵敏度,具体的传感原理如说明书附图2所示。It is worth noting that the present invention discloses a hydrazine sensing strategy for the chromophore generated by the condensation reaction between 4-diethylaminosalicylaldehyde (DEASA) and hydrazine. Among them, cetyltrimethylammonium bromide (CTAB) micelles provided stable hydrophobic cavities, which facilitated the condensation reaction of DEASA and hydrazine at the micellar interface. At the same time, the generated luminescent substance has better luminescent performance under the protection of CTAB micelles, so that the detection sensitivity can be improved. The specific sensing principle is shown in Figure 2 of the specification.
经由上述的技术方案可知,与现有技术相比,本发明公开了一种肼的零背景荧光检测方法及其应用,首先本发明提供了一种4-二乙氨基水杨醛在CTAB胶束中与肼反应生成新发色团作为肼检测指示剂的新型传感策略,该零背景检测模式具有超高灵敏度,适用于实际样品和生物体内痕量肼的检测;It can be known from the above-mentioned technical scheme that, compared with the prior art, the present invention discloses a zero-background fluorescence detection method for hydrazine and its application. First, the present invention provides a 4-diethylamino salicylaldehyde in CTAB micelles A new sensing strategy for the reaction of hydrazine with hydrazine to generate a new chromophore as an indicator for hydrazine detection. This zero-background detection mode has ultra-high sensitivity and is suitable for the detection of trace hydrazine in actual samples and organisms;
其次,本发明公开的检测方案建立在非荧光物质DEASA和肼的缩合反应的基础上,通过引入CTAB胶束为疏水性探针和亲水性肼提供合适的反应位点,反应效率得到了极大的提升,以含有分子内氢键的荧光产物HDBM作为荧光信号指示剂;Secondly, the detection scheme disclosed in the present invention is based on the condensation reaction of the non-fluorescent substance DEASA and hydrazine. By introducing CTAB micelles to provide suitable reaction sites for hydrophobic probes and hydrophilic hydrazine, the reaction efficiency has been greatly improved. Great improvement, using the fluorescent product HDBM containing intramolecular hydrogen bonds as a fluorescent signal indicator;
然后,本发明运用的CTAB胶束的使得在水溶液中对于肼的检测方便可行,而无需通过有机溶剂调节;Then, the CTAB micelles used in the present invention make the detection of hydrazine convenient and feasible in aqueous solution without adjustment by organic solvent;
最后,本发明公开的传感检测分析成功地在实际样品中进行对肼的检测,并且在活细胞成像中相当灵敏,对体内的肼的研究也进一步证明了其不受复杂环境的干扰和持久成像效果良好的性能。Finally, the sensing detection analysis disclosed in the present invention successfully detects hydrazine in actual samples, and is quite sensitive in live cell imaging. The research on hydrazine in vivo further proves that it is not disturbed by complex environments and durable Good imaging performance.
综上所述,本发明公开的检测方法能够高效选择性识别肼,并对肼具有很高的灵敏度。本发明提供了一种新的肼的检测途径,具有制备简便和良好的生物相容性等优点,这对于工业、生活和生物领域具有市场应用与推广价值。In summary, the detection method disclosed in the present invention can efficiently and selectively identify hydrazine, and has high sensitivity to hydrazine. The invention provides a new detection method for hydrazine, which has the advantages of simple preparation, good biocompatibility, etc., and has market application and promotion value for industry, life and biological fields.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据提供的附图获得其他的附图。In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only It is an embodiment of the present invention, and those skilled in the art can also obtain other drawings according to the provided drawings on the premise of not paying creative efforts.
图1为本发明HDBM在氘代DMSO中的核磁共振氢谱。Fig. 1 is the proton nuclear magnetic resonance spectrum of HDBM of the present invention in deuterated DMSO.
图2为本发明4-二乙基氨基水杨醛(DEASA)与肼之间的缩合反应生成发色团的肼传感原理图。Fig. 2 is a hydrazine sensing schematic diagram of the condensation reaction between 4-diethylaminosalicylaldehyde (DEASA) and hydrazine to generate a chromophore in the present invention.
图3为本发明DEASA与0.5mM肼在含有不同浓度CTAB时的荧光强度图。Fig. 3 is a diagram of the fluorescence intensity of DEASA of the present invention and 0.5 mM hydrazine when containing different concentrations of CTAB.
图4为本发明含有CTAB的DEASA溶液中和不同浓度肼的荧光光谱图。Fig. 4 is the fluorescence spectrogram of the DEASA solution containing CTAB and different concentrations of hydrazine in the present invention.
图5为本发明DEASA和CTAB溶液中含有肼和其他分析物的荧光光谱图。Fig. 5 is a fluorescence spectrogram of hydrazine and other analytes contained in DEASA and CTAB solutions of the present invention.
图6为本发明实际样品中肼的测定表。Fig. 6 is the determination table of hydrazine in the actual sample of the present invention.
图7为本发明分别用DEASA处理后,HeLa细胞与不同浓度肼的共聚焦荧光图像。Fig. 7 is the confocal fluorescence images of HeLa cells and different concentrations of hydrazine after being treated with DEASA in the present invention.
图8为本发明小鼠体内肼的荧光成像。Fig. 8 is the fluorescence imaging of hydrazine in mice of the present invention.
图9为本发明HeLa细胞存活率的柱形图。Fig. 9 is a bar graph of the survival rate of HeLa cells of the present invention.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
本发明实施例公开了一种在CTAB胶束中4-二乙氨基水杨醛与肼反应,生成新生色团作为肼指示剂的传感策略。The embodiment of the present invention discloses a sensing strategy in which 4-diethylamino salicylaldehyde reacts with hydrazine in CTAB micelles to generate a new chromophore as a hydrazine indicator.
为更好地理解本发明,下面通过以下实施例对本发明作进一步具体的阐述,但不可理解为对本发明的限定,对于本领域的技术人员根据上述发明内容所作的一些非本质的改进与调整,也视为落在本发明的保护范围内。For a better understanding of the present invention, the present invention will be further specifically described below through the following examples, but it should not be construed as a limitation of the present invention. For some non-essential improvements and adjustments made by those skilled in the art according to the above-mentioned content of the invention, It is also considered to fall within the protection scope of the present invention.
本发明公开了一种肼的零背景荧光检测方法,通过十六烷基三乙基溴化铵(CTAB)胶束促进4-二乙氨基水杨醛与分析物肼之间的缩合反应,原位生成的具有分子内氢键的新生色团作为肼检测的指示剂。The invention discloses a zero-background fluorescence detection method for hydrazine, which promotes the condensation reaction between 4-diethylamino salicylaldehyde and the analyte hydrazine through cetyltriethylammonium bromide (CTAB) micelles. A new chromophore with intramolecular hydrogen bonding generated at the site was used as an indicator for the detection of hydrazine.
本发明新生色团—发光物质HDBM的生成,是在比色管中加入PBS缓冲溶液作为溶剂,然后加入探针DEASA和CTAB,最后加入分析物肼,在CTAB胶束中发生缩合反应,最终生成发光物质HDBM。The generation of the new chromophore-luminescent substance HDBM of the present invention is to add PBS buffer solution as a solvent in the colorimetric tube, then add probes DEASA and CTAB, and finally add analyte hydrazine, and condensation reaction occurs in CTAB micelles, finally forming Luminescent material HDBM.
具体制备方案如下:Concrete preparation scheme is as follows:
在5mL比色管中加入2mL的纯水溶液作为溶剂,向其中加入20μL DEASA的DMSO溶液(5×10-3mol·L-1)后,然后加入CTAB的水溶液(1×10-3mol·L-1),再加入0.5当量的肼,即得到发光物质HDBM。Add 2 mL of pure aqueous solution as a solvent to a 5 mL colorimetric tube, add 20 μL of DEASA in DMSO (5×10 -3 mol·L -1 ), and then add CTAB in water (1×10 -3 mol·L -1 ), then add 0.5 equivalent of hydrazine to obtain the luminescent substance HDBM.
为了进一步验证本发明的优异效果,发明人还进行了如下实验:In order to further verify the excellent effect of the present invention, the inventor has also carried out the following experiments:
实验1:发光物质HDBM的合成及结构表征Experiment 1: Synthesis and structural characterization of luminescent material HDBM
1、发光物质HDBM的合成1. Synthesis of luminescent material HDBM
在5mL比色管中加入2mL的纯水溶液作为溶剂,向其中加入20μL DEASA的DMSO溶液(5×10-3mol·L-1)后,然后加入CTAB的水溶液(1×10-3mol·L-1),再加入0.5当量的肼,即得到发光物质HDBM。Add 2 mL of pure aqueous solution as a solvent to a 5 mL colorimetric tube, add 20 μL of DEASA in DMSO (5×10 -3 mol·L -1 ), and then add CTAB in water (1×10 -3 mol·L -1 ), then add 0.5 equivalent of hydrazine to obtain the luminescent substance HDBM.
2、测试分析2. Test analysis
发光物质HDBM的1HNMR谱峰值为:The peak value of the 1 HNMR spectrum of the luminescent substance HDBM is:
1H NMR(500MHz,DMSO-d6)δ(ppm)11.47(s,2H),8.59(s,2H),7.26(d,J=8.8Hz,2H),6.30-6.28(m,2H),6.10(d,J=1.7Hz,2H),3.36(q,J=6.9Hz,4H),2.48(t,J=7.0Hz,4H); 1 H NMR (500MHz, DMSO-d6) δ (ppm) 11.47 (s, 2H), 8.59 (s, 2H), 7.26 (d, J = 8.8Hz, 2H), 6.30-6.28 (m, 2H), 6.10 (d, J=1.7Hz, 2H), 3.36(q, J=6.9Hz, 4H), 2.48(t, J=7.0Hz, 4H);
13CNMR谱峰值为: 13 CNMR spectrum peak is:
13C NMR(126MHz,DMSO-d6)δ(ppm)δ161.08,133.44,106.85,104.49,97.50,44.29,12.99. 13 C NMR (126MHz, DMSO-d6) δ (ppm) δ 161.08, 133.44, 106.85, 104.49, 97.50, 44.29, 12.99.
通过本发明公开的合成方法制得发光物质的H谱图和C谱图得知,附图中的谱峰值与HDBM一一对应,即可证明发光物质HDBM合成成功。According to the H spectrum and C spectrum of the luminescent substance prepared by the synthesis method disclosed in the present invention, the spectrum peaks in the drawings correspond to HDBM one by one, which proves that the synthesis of the luminescent substance HDBM is successful.
实验2:一种基于肼的零背景荧光检测方法在溶剂体系中检测肼的具体应用Experiment 2: A specific application of a hydrazine-based zero-background fluorescence detection method for the detection of hydrazine in a solvent system
1、测试实验1. Test experiment
在含有1.0mM CTAB和50μM DEASA的水溶液中,依次向每支比色管中分别加入肼、K+、Na+、Mg2+、Ca2+、F-、Cl-、NO3 -、Glu,Cys、Gly、苯胺的水溶液(1×10-4mol·L-1),混匀后,测试其荧光光谱,参见附图5(A)。In the aqueous solution containing 1.0mM CTAB and 50μM DEASA, add hydrazine, K + , Na + , Mg 2+ , Ca 2+ , F - , Cl - , NO 3 - , Glu to each colorimetric tube in sequence, Aqueous solutions of Cys, Gly, and aniline (1×10 -4 mol·L -1 ), after mixing, tested their fluorescence spectra, see Figure 5(A).
对比的,在含有1.0mM CTAB、100μM肼和50μM DEASA的水溶液中,依次向每支比色管中分别加入肼、K+、Na+、Mg2+、Ca2+、F-、Cl-、NO3 -、Glu,Cys、Gly、苯胺的水溶液(1×10-4mol·L-1),混匀后,测试其荧光光谱,参见附图5(B)。In contrast, in an aqueous solution containing 1.0 mM CTAB, 100 μM hydrazine and 50 μM DEASA, hydrazine, K + , Na + , Mg 2+ , Ca 2+ , F - , Cl - , The aqueous solution (1×10 -4 mol·L -1 ) of NO 3 - , Glu, Cys, Gly, and aniline was mixed well, and its fluorescence spectrum was tested, see Figure 5(B).
2、测试分析2. Test analysis
探针DEASA对肼具有相对选择性,实验中涉及多种潜在的干扰化合物,如阳离子(K+,Na+,Mg2+和Ca2+),阴离子(F-,Cl-和NO3 -),氨基酸(Glu,Cys和Gly)和甚至类似物(苯胺),荧光响应只能由肼引发,而潜在的干扰物种几乎不会引起光谱变化。进一步的对比试验测定显示出干扰物的共存对DEASA对肼的响应几乎没有影响。Probe DEASA is relatively selective to hydrazine, and a variety of potential interfering compounds are involved in the experiment, such as cations (K + , Na + , Mg 2+ and Ca 2+ ), anions (F - , Cl - and NO 3 - ) , amino acids (Glu, Cys, and Gly) and even analogues (aniline), the fluorescence response can only be elicited by hydrazine, while potentially interfering species cause little spectral change. Further comparative experiments showed that the coexistence of interfering substances had almost no effect on the response of DEASA to hydrazine.
上述结果表明,探针DEASA对肼的检测具有很强的特异性,并适用于生理环境中的检测,这可能是由基于特定反应的传感策略提供的,提供了空白背景和原位生成的信号系统。The above results indicate that the probe DEASA has strong specificity for the detection of hydrazine and is suitable for detection in a physiological environment, which may be provided by a specific reaction-based sensing strategy that provides a blank background and in situ generated signal system.
综上,本发明可实现在水溶液中选择性识别肼。In summary, the present invention can realize the selective recognition of hydrazine in aqueous solution.
实验3:探针DEASA对肼定量检测的最低检测限的测定Experiment 3: Determination of the minimum detection limit of the probe DEASA for the quantitative detection of hydrazine
在25℃时,利用荧光发射光谱,根据肼对含有1.0mMCTAB和50μM DEASA的滴定实验,通过3σ/k计算,得到探针DEASA对肼的最低检测限达0.42nM,说明该方法对肼的检测灵敏度高,表明该探针DEASA在CTAB胶束中对肼高效检测方面有潜在的应用价值。At 25°C, using fluorescence emission spectroscopy, according to the titration experiment of hydrazine with 1.0mMCTAB and 50μM DEASA, through 3σ/k calculation, the lowest detection limit of probe DEASA for hydrazine is 0.42nM, indicating that the method can detect hydrazine The high sensitivity indicates that the probe DEASA has potential application value in the high-efficiency detection of hydrazine in CTAB micelles.
实验4:上述肼的零背景荧光检测方法在实际水和血清样本、活细胞甚至小鼠成像中检测肼的具体应用Experiment 4: Specific application of the above-mentioned zero-background fluorescence detection method for hydrazine in real water and serum samples, live cells, and even mouse imaging
(1)检测方法在实际水样和血清样本中检测肼的具体应用(1) Specific application of the detection method to detect hydrazine in actual water samples and serum samples
首先,将所提出的传感分析方法应用于自来水中的检测,分别检测从五个地方收集的海水,污水和稀释的人血清中的肼含量,测试结果如图6所示。从图6显示的实际样品中肼的测定表得知,回收率和相对标准偏差(RSD)值都在正常范围以内,另外2个高水平的肼含量(分别为2μM和10μM),揭示了污水中的肼残留。上述结果表明,探针DEASA和所提出的原位检测设计可适用于实际样品的定量分析。First, the proposed sensing analysis method was applied to the detection of tap water, and the hydrazine content in seawater, sewage and diluted human serum collected from five places were detected respectively, and the test results are shown in Fig. 6. From the determination table of hydrazine in the actual sample shown in Figure 6, the recoveries and relative standard deviation (RSD) values are within the normal range, the other two high levels of hydrazine content (respectively 2μM and 10μM), revealing that the sewage hydrazine residues. The above results demonstrate that the probe DEASA and the proposed in situ detection design can be applied to the quantitative analysis of real samples.
(2)检测方法在活细胞中检测肼的具体应用(2) Specific application of the detection method to detect hydrazine in living cells
将HeLa细胞与50μM探针DEASA一起孵育1小时,用PBS缓冲液洗涤后,加入不同浓度(从10μM增加至150μM)的肼再培养2小时,未用肼进一步处理的细胞作为对照样品,如图7所示。其中图7(a)~图7(e)依次为肼浓度分别为0μM、10μM、50μM、100μM、150μM时的细胞荧光成像。HeLa cells were incubated with 50 μM probe DEASA for 1 hour, washed with PBS buffer, and then added with different concentrations of hydrazine (increased from 10 μM to 150 μM) for another 2 hours. Cells that were not further treated with hydrazine were used as control samples, as shown in the figure 7. 7(a) to 7(e) show the fluorescence imaging of cells when the hydrazine concentrations are 0 μM, 10 μM, 50 μM, 100 μM, and 150 μM, respectively.
从图7得知,未用肼进一步处理的细胞显示完全黑暗的荧光,说明探针DEASA连同反应介质CTAB胶束不能触发任何荧光反应。该零响应肯定了传感测定的零背景性质,并排除了活细胞中不同组分干扰的可能性。另外,在用10μM肼处理HeLa细胞后可以捕获明显的绿色荧光发射,这验证了生物成像的原位传感的可行性。From Fig. 7, cells not further treated with hydrazine showed completely dark fluorescence, indicating that the probe DEASA together with the reaction medium CTAB micelles could not trigger any fluorescent reaction. This zero response affirms the zero-background nature of the sensing assay and rules out the possibility of interference from different components in living cells. In addition, obvious green fluorescence emission could be captured after HeLa cells were treated with 10 μM hydrazine, which verified the feasibility of in situ sensing for bioimaging.
(3)检测方法在生物体中检测肼的具体应用(3) The specific application of the detection method in the detection of hydrazine in organisms
将探针DEASA(40μL,50μM的DMSO溶液)通过皮肤注射到裸鼠中,并且分别在注射0和2小时后拍摄前两个成像图片,如图8所示。小鼠本身不发光,而荧光图像在2小时内仍然不发光,证明了DEASA在复杂生物环境中的相对稳定性。在拍摄第二张照片后不久,在相同部位注射另外的肼(2μL,0.1M),并按照计划时间表捕获荧光图像,随后在注射肼后6小时观察到荧光成像,其源自于DEASA与肼反应的过程中产生的发光产物HDBM,说明本发明提出的原位传感策略也可应用于生物体。The probe DEASA (40 μL, 50 μM in DMSO solution) was injected through the skin into nude mice, and the first two imaging pictures were taken at 0 and 2 hours after the injection, respectively, as shown in FIG. 8 . The mouse itself does not emit light, while the fluorescent image still does not emit light within 2 hours, proving the relative stability of DEASA in complex biological environments. Shortly after taking the second picture, additional hydrazine (2 μL, 0.1 M) was injected at the same site, and fluorescence images were captured according to the planned schedule, followed by observation of fluorescence imaging 6 hours after hydrazine injection, which was derived from DEASA with The luminescent product HDBM produced during the hydrazine reaction indicates that the in situ sensing strategy proposed by the present invention can also be applied to organisms.
此外,在24小时的实时检测期间获得的发射强度也可归一量化,并在24小时后仍然可以获得强荧光而没有强度损失,这表明在分析中原位生成的发光物具有持久有效成像的优点。因此,该方案显示出的良好响应特征和高稳定性,以使本发明公开的检测方法即使在生物水平上也可通过原位缩合反应实现肼的检测。In addition, the emission intensity obtained during the 24-hour real-time detection period can also be normalized and quantified, and strong fluorescence can still be obtained after 24 hours without intensity loss, which indicates that the in situ generated luminescent species in the assay has the advantage of long-lasting and effective imaging. . Therefore, the good response characteristics and high stability exhibited by this scheme enable the detection method disclosed in the present invention to realize the detection of hydrazine through in-situ condensation reaction even at the biological level.
综上,本发明公开的检测方法能够成功地应用在活细胞成像及小鼠体成像,以说明上述零背景荧光检测方法具有良好的生物相容性。并且为了进一步证明检测方法的生物相容性,申请人还对HeLa细胞毒性进行了表征分析,具体实验结果如实验5所示。In summary, the detection method disclosed in the present invention can be successfully applied to live cell imaging and mouse body imaging, which shows that the above-mentioned zero-background fluorescence detection method has good biocompatibility. And in order to further prove the biocompatibility of the detection method, the applicant also performed a characterization analysis on HeLa cytotoxicity, and the specific experimental results are shown in Experiment 5.
实验5:上述肼的零背景荧光检测方法的细胞毒性实验Experiment 5: Cytotoxicity experiment of the zero-background fluorescence detection method for hydrazine above
将HeLa细胞接种于96孔板中,孵育24h,加入50μM探针DEASA分别孵育0、1、2、4、8、12、24小时后,用磷酸盐缓冲液冲洗细胞,并采用CCK-8法检测细胞毒性,其中HeLa细胞存活率的柱形图如图9所示。HeLa cells were seeded in a 96-well plate, incubated for 24 hours, added 50 μM probe DEASA and incubated for 0, 1, 2, 4, 8, 12, and 24 hours, respectively, and then washed the cells with phosphate buffer, and used the CCK-8 method To detect cytotoxicity, the bar graph of the survival rate of HeLa cells is shown in FIG. 9 .
从附图9可知,在50μM DEASA孵育24小时后细胞存活率依然保持在90%以上,得以证明DEASA具有相对较低的细胞毒性,该结果显示了探针DEASA对活细胞中肼的生物成像研究具有良好的生物相容性。It can be seen from Figure 9 that the cell survival rate remains above 90% after 24 hours of incubation with 50 μM DEASA, which proves that DEASA has relatively low cytotoxicity. This result shows the bioimaging study of the probe DEASA on hydrazine in living cells Has good biocompatibility.
综上所述,本发明提出了一种多功能和直接的肼检测策略,具有无背景干扰的检测功能,适用于实际样品和生物体内检测。CTAB胶束的使得检测在水溶液中可行,而无需通过有机溶剂调节,并且通过原位检测方案,探针DEASA对肼的灵敏度和选择性相对较高,无背景性质也可用于细胞内成像甚至生物分析。本发明公开的良好的肼荧光检测传感方案为实现目标物的高灵敏度零背景检测提供了新的检测途径,这对于工业、生活和生物领域是极具有市场应用与推广价值的。In conclusion, the present invention proposes a multifunctional and direct hydrazine detection strategy with background-free detection function, suitable for real samples and in vivo detection. The advantages of CTAB micelles make the detection feasible in aqueous solution without adjustment by organic solvents, and through the in situ detection scheme, the probe DEASA has relatively high sensitivity and selectivity for hydrazine, and the background-free property can also be used for intracellular imaging and even biological analyze. The excellent hydrazine fluorescence detection and sensing scheme disclosed in the present invention provides a new detection approach for high-sensitivity and zero-background detection of target objects, which is extremely valuable for market application and promotion in the fields of industry, life and biology.
对所公开的实施例及实验例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。The above descriptions of the disclosed embodiments and experimental examples enable those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the present invention will not be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910406958.3A CN110261353A (en) | 2019-05-16 | 2019-05-16 | A kind of zero background fluorescence detection method and its application of hydrazine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910406958.3A CN110261353A (en) | 2019-05-16 | 2019-05-16 | A kind of zero background fluorescence detection method and its application of hydrazine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110261353A true CN110261353A (en) | 2019-09-20 |
Family
ID=67914761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910406958.3A Pending CN110261353A (en) | 2019-05-16 | 2019-05-16 | A kind of zero background fluorescence detection method and its application of hydrazine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110261353A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060046171A1 (en) * | 2004-08-30 | 2006-03-02 | Ruta Budreckiene | Hydrazone-based charge transport materials having an unsaturated acyl group |
CN104530415A (en) * | 2014-10-01 | 2015-04-22 | 厦门赛诺邦格生物科技有限公司 | Hetero-functionalized Y-type polyethylene glycol derivative, preparation method and biologically related substance thereof |
CN106496067B (en) * | 2015-09-07 | 2018-08-07 | 香港科技大学深圳研究院 | Buzane base azine structural compounds and its preparation method and application based on meta position link |
CN108530483A (en) * | 2018-01-15 | 2018-09-14 | 四川大学 | Wittig reagents based on coumarin skeleton and its preparation method and application |
-
2019
- 2019-05-16 CN CN201910406958.3A patent/CN110261353A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060046171A1 (en) * | 2004-08-30 | 2006-03-02 | Ruta Budreckiene | Hydrazone-based charge transport materials having an unsaturated acyl group |
CN104530415A (en) * | 2014-10-01 | 2015-04-22 | 厦门赛诺邦格生物科技有限公司 | Hetero-functionalized Y-type polyethylene glycol derivative, preparation method and biologically related substance thereof |
CN106496067B (en) * | 2015-09-07 | 2018-08-07 | 香港科技大学深圳研究院 | Buzane base azine structural compounds and its preparation method and application based on meta position link |
CN108530483A (en) * | 2018-01-15 | 2018-09-14 | 四川大学 | Wittig reagents based on coumarin skeleton and its preparation method and application |
Non-Patent Citations (3)
Title |
---|
DONG HEE MA ET AL.,: ""An FITC-BODIPY FRET Couple : Application to Selective,Ratiometric Detection and Bioimaging of Cysteine"", 《CHEMISTRY-AN ASIAN JOURNAL》 * |
XIAOTONG CHEN ET AL.,: ""Sensitive and selective fluorescence determination of trace hydrazine in aqueous solution utilizing 5-chlorosalicylaldehyde"", 《ANALYTICA CHIMICA ACTA 》 * |
姜秀娟等: ""铜(Ⅱ)荧光探针的合成及其识别性能研究"", 《分析试验室》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107699234B (en) | A kind of Schiff base multifunctional fluorescent probe and its preparation method and application | |
CN110437199B (en) | Selenium cysteine near-infrared fluorescent probe and preparation method and application thereof | |
CN110229147A (en) | A kind of cumarin-benzothiazolyl hydrazone compounds and its preparation method and application | |
CN108129459A (en) | A kind of novel fluorescence probe and its application for being used to detect sulfur dioxide | |
CN107121415A (en) | The method of the label-free fluorescence quick detection mercury ion of single step | |
CN104877672A (en) | Two-photon fluorescent probe for identifying palladium (0) and preparation method and application of two-photon fluorescent probe | |
CN108398409A (en) | A kind of method of ratio fluorescent detection hypochlorite | |
CN106146526B (en) | Fluorescent probe compound and preparation method and application thereof | |
CN101446547A (en) | Zinc and copper ion fluorescence probe and preparation method and application thereof | |
CN104788344B (en) | A kind of bifunctional fluorescent probe with anthracene as parent, preparation method and application | |
CN110452250A (en) | A kind of detection hydrazine fluorescence probe of fluorescein precursor structure | |
Rajalakshmi et al. | A new recognition moiety diphenylborinate in the detection of pyruvate via Lewis acid/base sensing pathway and its bioimaging applications | |
CN110669503B (en) | Preparation and application of carbon monoxide near-infrared fluorescent probe | |
Zhang et al. | In situ generated chromophore as the indicator for background-free sensing strategy of hydrazine with high sensitivity with in vitro and in vivo applications | |
CN110261353A (en) | A kind of zero background fluorescence detection method and its application of hydrazine | |
CN105928912A (en) | Heparin detection method | |
CN117447392A (en) | Fluorescent material and preparation method and application thereof | |
CN114478513B (en) | Glutathione fluorescent probe and application thereof | |
CN109970618A (en) | A ratiometric near-infrared fluorescent probe and its preparation method and application | |
CN111635388B (en) | Bisulfite Fluorescent Probe Based on Pyrene and Coumarin Derivatives, Preparation Method and Application | |
CN106957267B (en) | A novel reversible colorimetric ratio phenanthroimidazole fluorescent molecular probe for the detection of palladium | |
Tang et al. | Ruthenium bipyridine complexes as electrochemiluminescent transducers for ionophore-based ion-selective detection | |
CN107286056B (en) | Polyamide-anthracene-based Schiff base-containing fluorescent probe compound and preparation method and application thereof | |
CN110483512A (en) | A kind of quinoline acid imide probe molecule and its synthetic method and application, quinoline acid imide probe molecule complex compound and its application | |
CN119059960B (en) | Hg (Hg) detection method for double-channel detection2+And Ag+Near infrared fluorescent probe of (2), preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190920 |